Hirotomo Tanaka Selected Research

Hirotomo Tanaka Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 01/2010
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2013
4	Lymphoma (Lymphomas) 09/2023 - 03/2012
3	Glioma (Gliomas) 10/2019 - 02/2013
3	Brain Neoplasms (Brain Tumor) 08/2018 - 01/2010
2	Aneurysm (Aneurysms) 01/2023 - 08/2014
2	Pathologic Constriction (Stenosis) 10/2021 - 09/2021
2	Neoplasm Metastasis (Metastasis) 04/2019 - 01/2010
1	Graves Ophthalmopathy 03/2024
1	Radiation induced meningioma 03/2024
1	Hyperthyroidism 03/2024
1	Meningioma (Meningiomas) 03/2024
1	Facial Paralysis (Facial Palsy) 09/2023
1	Hearing Loss (Hearing Impairment) 09/2023
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 01/2023
1	Epilepsy (Aura) 01/2022
1	Stroke (Strokes) 10/2021
1	Paresis (Hemiparesis) 09/2021
1	Starvation 01/2021
1	Medulloblastoma 08/2018
1	Putaminal Hemorrhage 07/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015
1	Pituitary Neoplasms (Pituitary Adenoma) 08/2014
1	Diplopia (Double Vision) 08/2014
1	Rupture 08/2014
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2014
1	Prolactinoma (Prolactinomas) 08/2014
1	Sarcoma (Soft Tissue Sarcoma) 01/2010

Drug/Important Bio-Agent (IBA)

4	Interleukin-10 (Interleukin 10)IBA 01/2020 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 10/2019 - 03/2012
3	GadoliniumIBA 08/2018 - 10/2012
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 02/2013
2	SteroidsIBA 03/2024 - 09/2023
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2012
2	CytokinesIBA 10/2019 - 09/2015
2	MethyltransferasesIBA 06/2013 - 01/2010
2	AcidsIBA 05/2013 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 01/2010
1	serpentine (alkaloid)IBA 01/2023
1	CreatineIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Ketone BodiesIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Amino Acids FDA Link 01/2021
1	LigandsIBA 01/2020
1	succinyl- interleukin-2IBA 01/2020
1	ChemokinesIBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 04/2019
1	Natriuretic PeptidesIBA 08/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2016
1	ProlactinIBA 08/2014
1	Cabergoline FDA LinkGeneric 08/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2013
1	isocitric acid (isocitrate)IBA 05/2013
1	alpha-aminopimelic acidIBA 05/2013
1	Small Interfering RNA (siRNA)IBA 02/2013
1	3' Untranslated Regions (3' UTR)IBA 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	RNA (Ribonucleic Acid)IBA 02/2013
1	LuciferasesIBA 02/2013
1	Temozolomide (Temodar)FDA LinkGeneric 01/2010

Therapy/Procedure

5	Therapeutics 03/2024 - 08/2014
3	Craniotomy 03/2024 - 08/2014
3	Radiotherapy 03/2024 - 01/2010
2	Drug Therapy (Chemotherapy) 06/2013 - 01/2010
1	Combined Modality Therapy 10/2021
1	Thrombectomy 10/2021
1	Stents 10/2021
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2021
1	Ketogenic Diet 01/2021
1	Aftercare (After-Treatment) 08/2014
1	Chemoradiotherapy 06/2013